Showing results (81-90 of 161) with videos related to

Sort By:
Pageof 17
Cancer Research|December 11, 2012
TWIST1 is an ERK1/2 effector that promotes invasion and regulates MMP-1 expression in human melanoma cellsMichele B Weiss, Ethan V Abel, Melanie M Mayberry, et al.
Pigment Cell & Melanoma Research|August 4, 2021
The AMP-dependent kinase pathway is upregulated in BAP1 mutant uveal melanomaVivian Chua, Anna Han, Nelisa Bechtel, et al.
Molecular Cancer Research : MCR|August 31, 2022
Raptinal Induces Gasdermin E-Dependent Pyroptosis in Naïve and Therapy-Resistant MelanomaMegane Vernon, Nicole A Wilski, Daniel Kotas, et al.
Cancer Causes & Control : CCC|January 4, 2023
Engaging community members in cancer research: an assessment of an NCI-designated cancer centerAmy E Leader, Rebecca J Melillo, Quincy Greene, et al.
The Journal of Investigative Dermatology|March 12, 2016
MIG6 Is MEK Regulated and Affects EGF-Induced Migration in Mutant NRAS MelanomaHa Linh Vu, Sheera Rosenbaum, Claudia Capparelli, et al.
Cancer Research|February 4, 2015
Human pancreatic cancer tumors are nutrient poor and tumor cells actively scavenge extracellular proteinJurre J Kamphorst, Michel Nofal, Cosimo Commisso, et al.
Journal of Translational Medicine|June 25, 2017
Establishment of an orthotopic patient-derived xenograft mouse model using uveal melanoma hepatic metastasisKen Kageyama, Masahiro Ohara, Kengo Saito, et al.
Cancer Research|August 5, 2016
An In Vivo Reporter to Quantitatively and Temporally Analyze the Effects of CDK4/6 Inhibitor-Based Therapies in MelanomaJessica L F Teh, Timothy J Purwin, Evan J Greenawalt, et al.
Pigment Cell & Melanoma Research|June 29, 2019
C57BL/6 congenic mouse NRASQ61K melanoma cell lines are highly sensitive to the combination of Mek and Akt inhibitors in vitro and in vivoValérie Petit, Jeremy Raymond, Christophe Alberti, et al.
Pageof 17